Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03617185 · ClinicalTrials.gov registry record · NA
Effect of Exercise and Surgical Weight Loss on Polyneuropathy
A NA study of Obesity and Bariatric Surgery Candidate, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 140
- Enrollment target
- 1
- Study location
NCT03617185: Completed NA study of Obesity and Bariatric Surgery Candidate, sponsored by University of Michigan.
NCT03617185 is a NA study of Obesity and Bariatric Surgery Candidate that has completed, run by University of Michigan. The registered enrollment target is 140 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03617185, a NA study of Obesity and Bariatric Surgery Candidate, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 140 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to evaluate how exercise and surgical weight loss affect how likely an individual is to develop peripheral neuropathy and other neurologic complications.
Primary Outcome
Intraepidermal Nerve Fiber Density (IENFD) as assessed by 3mm skin biopsies at the proximal thigh.
Conditions Studied
Interventions
- PROCEDURE Bariatric surgery
- OTHER High Intensity Interval Training (HIIT)
- OTHER Routine Exercise
Study Locations (1)
Michigan
- University Of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2018-07-27 |
| Est. Completion | 2024-08-01 |
| Phase | NA |
What the finished NCT03617185 record still lists
NCT03617185 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (83% lower).
The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which Bariatric surgery is the first listed.
NCT03617185 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT03617185 about?
NCT03617185 is a clinical study titled "Effect of Exercise and Surgical Weight Loss on Polyneuropathy". The purpose of this research study is to evaluate how exercise and surgical weight loss affect how likely an individual is to develop peripheral neuropathy and other neurologic complications.
What is the current status of trial NCT03617185?
This trial is currently completed. It is a NA study. The enrollment target is 140 participants. The study started on 2018-07-27. Estimated completion is 2024-08-01.
What conditions does trial NCT03617185 study?
This clinical trial studies the following conditions: Obesity, Bariatric Surgery Candidate, Polyneuropathies.
What interventions are being tested in trial NCT03617185?
The interventions under investigation include: Bariatric surgery (PROCEDURE), High Intensity Interval Training (HIIT) (OTHER), Routine Exercise (OTHER).
Who is sponsoring clinical trial NCT03617185?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03617185 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03617185's enrollment target sits among peer trials
140 401st of 1053 higher than 650 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI